A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery

This publication has 16 references indexed in Scilit:

• Distinct molecular sites of anaesthetic action: pentobarbital block of human brain sodium channels is alleviated by removal of fast inactivation
  British Journal of Anaesthesia, 1999
• Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers
  Clinical Drug Investigation, 1999
• PLA2 antagonists suppress inducible nitric oxide synthase and inducible cyclooxygenase in lipopolysaccharide-induced Raw264.7 cells
  Critical Care, 1999
• Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers
  Clinical Drug Investigation, 1998
• Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass
  European Journal of Cardio-Thoracic Surgery, 1997
• Réactions anaphylactoïdes aux substituts colloïdaux du plasma : incidence, facteurs de risque, mécanismes: Enquête prospective multicentrique française
  Annales Françaises dʼAnesthésie et de Réanimation, 1994
• Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers
  Critical Care Medicine, 1994
• Pentastarch may cause fewer effects on coagulation than hetastarch
  Transfusion, 1988
• A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness
  Anaesthesia, 1988
• Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII
  Transfusion, 1985